Autoimmune hemolytic anemia in a patient with acute myelogenous leukemia treated with low-dose interleukin-2 after autologous bone marrow transplantation.
Meloni
G
G
Andrizzi
C
C
Vignetti
M
M
Girelli
G
G
Mandelli
F
F
D000208:Acute Disease; D000743:Anemia, Hemolytic / Q000139:chemically induced*; D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced*; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects*; D007951:Leukemia, Myeloid / Q000628:therapy; D016131:Lymphocyte Subsets / Q000276:immunology / Q000378:metabolism; D008875:Middle Aged; D015375:Receptors, Interleukin-2 / Q000187:drug effects; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D012074:Remission Induction
D007376:Interleukin-2; D015375:Receptors, Interleukin-2; D011994:Recombinant Proteins